Pfizer wraps deal for GSK's meningococcal vaccines; Indivior to fight Sandoz's suboxone copycat plans;

> Pfizer ($PFE) wrapped up its $130 million buyout of two GlaxoSmithKline ($GSK) meningococcal vaccines, Nimenrix and Mencevax. Report

> Indivior plans to sue Novartis' ($NVS) generics unit Sandoz for patent infringement after the latter filed for FDA approval for a copycat version of suboxone sublingual film. Report

> A new Cuban vaccine against hepatitis B is going through the process of clinical evaluation in 8 Asian countries in alliance with the French company Abivax. Report

> Diabetes drugs made by Novo Nordisk ($NVO) in partnership with the Algerian pharma Saidal will begin to be exported from that country beginning next year. Report

And Finally... Following European regulators, Brazil halted the use of breast implants made by a domestic devicemaker Silimed. Report

Suggested Articles

When it comes to COVID-19 vaccines and treatments, more news is good news. That’s the latest takeaway from consumer sentiment tracking by Harris Poll.

In previously untreated nonsquamous NSCLC, a Tyvyt-chemo combo beat chemo alone at stalling the time to tumor progression or death.

Roche’s Tecentriq didn't repeat its prior TNBC success when tested in tandem with chemo med paclitaxel in previously untreated metastatic patients.